Neural precursor cells and their role in neuro-oncology

Developmental Neuroscience

Volumn 26, Issue 2-4, 2004, Pages 118-130

  Shah, Khalid ^a   Hsich, Gary ^a   Breakefield, Xandra O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain; Gene therapy; Glioma; Stem cells; Virus vectors

Indexed keywords

FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; INTERLEUKIN 12; INTERLEUKIN 4; MIMOSINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BRAIN TUMOR; CELL DIFFERENTIATION; CELL KILLING; CELL MIGRATION; CELL PROLIFERATION; GENE THERAPY; GENETICS; IMAGING; LUMINESCENCE; MONITORING; NERVE CELL; NONHUMAN; ONCOLOGY; PRIORITY JOURNAL; REVIEW; STEM CELL; TUMOR CELL; ANIMAL; CELL MOTION; CYTOLOGY; GENE TRANSFER; GENE VECTOR; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN NEOPLASMS; CELL MOVEMENT; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MEMBRANE GLYCOPROTEINS; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17444365444     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082132     Document Type: Review

References (126)

1. Orkin SH, Morrison SJ: Stem-cell competition. Nature 2002;418:25-27.
2. Juttner CA, To LB, Haylock DN, Dyson PG, Thorp D, Dar GW, Ho JQ, Horvath N, Bardy P: Autologous blood stem cell transplantation. Transplant Proc 1989;21:2929-2931.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
4. Slack JM: Stem cells in epithelial tissues. Science 2000;287:1431-1433.
5. Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778-784.
6. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH: Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228.
7. Alison M, Sarraf C: Hepatic stem cells. J Hepatol 1998;29:676-682.
8. Suzuki A, Zheng YW, Kaneko S, Onodera M, Fukao K, Nakauchi H, Taniguchi H: Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 2002;156:173-184.
9. Karam SM: Lineage commitment and maturation of epithelial cells in the gut. Frontiers Biosci 1999;4:286-298.
10. Seale P, Rudnicki MA: A new look at the origin, function, and 'stem-cell' status of muscle satellite cells. Dev Biol 2000;218:115-124.
11. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U, Frisen J: Generalized potential of adult neural stem cells. Science 2000;288:1660-1663.
12. Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J: Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999;96:25-34.
13. McKay R: Stem cells in the central nervous system. Science 1997;276:66-71.
14. Gage FH: Mammalian neural stem cells. Science 2000;287:1433-1438.
15. Altman J: Are new neurons formed in the brains of adult mammals? Science 1962;30:1127-1128.
16. Altman J, Das GD: Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965;124:319-335.
17. Lendahl U, Zimmerman LB, McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 1990;60:585-595.
18. Kiss JZ, Muller D: Contribution of the neural cell adhesion molecular to neuronal and synaptic plasticity. Rev Neurosci 2001;12:297-310.
19. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL: Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-537.
20. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998;279:1528-1530.
21. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1129-1134.
22. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR: Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-1782.
23. Tosh D, Slack JM: How cells change their phenotype. Nat Rev Mol Cell Biol 2002;3:187-194.
24. Galli R, Gritti A, Bonfanti L, Vescovi AL: Neural stem cells: An overview. Circ Res 2003;92:598-608.
25. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542-545.
26. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A: Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003;425:968-973.
27. Yagita Y, Kitagawa K, Ohtsuki T, Takasawa KI, Miyata T, Okano H, Hori M, Matsumoto M: Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 2001;32:1890-1896.
28. Weiss S: Pathways for neural stem cell biology and repair. Nat Biotechnol 1999;17:850-851.
29. Gritti A, Parati EA, Cova L, Frolichsthal P, Galli R, Wanke E, Faravelli L, Morassutti DJ, Roisen F, Nickel DD, Vescovi AL: Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J Neurosci 1996;16: 1091-1100.
30. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FH: Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci 1997;17:5820-5829.
31. Luskin MB: Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 1993;11:173-189.
32. Cameron HA, Gould E: Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994;61:203-209.
33. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH: Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-1317.
34. Kornack DR, Rakic P: Continuation of neurogenesis in the hippocampus of the adult macaque monkey. Proc Natl Acad Sci USA 1999;96:5768-5773.
35. Vescovi AL, Snyder EY: Establishment and properties of neural stem cell clones: Plasticity in vitro and in vivo. Brain Pathol 1999;9:569-598.
36. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY: Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat Biotechnol 1998;16:1033-1039.
37. Ourednik V, Ourednik J, Flax JD, Zawada WM, Hutt C, Yang C, Park KI, Kim SU, Sidman RL, Freed CR, Snyder EY: Segregation of human neural stem cells in the developing primate forebrain. Science 2001;293:1820-1824.
38. Zhang RL, Zhang ZG, Zhang L, Chopp M: Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 2001;105:33-41.
39. Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO: Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 2000;1:347-357.
40. Franceschini IA, Feigenbaum-Lacombe V, Casanova P, Lopez-Lastra M, Darlix JL, Dalcq MD: Efficient gene transfer in mouse neural precursors with a bicistronic retroviral vector. J Neurosci Res 2001;65:208-219.
41. Arenijevic Y, Villemure JG, Brunet JF, Bloch JJ, Deglon N, Kostic C, Zurn A, Aebischer P: Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol 2001;170:48-62.
42. Hughes SM, Moussavi-Harami F, Sauter SL, Davidson BL: Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol Ther 2002;5:16-24.
43. Passini MA, Watson DJ, Vite CH, Landsburg DJ, Peigenbaum AL, Wolfe JH: Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice. J Virol 2003;77:7034-7040.
44. Wang C, Wang CM, Clark KR, Sferra TJ: Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Ther 2003;10:1528-1534.
45. Noble M, Groves AK, Ataliotis P, Jat PS: From chance to choice in the generation of neural cell lines. Brain Pathol 1992;2:39-46.
46. Snyder EY: Grafting immortalized neurons to the CNS. Curr Opin Neurobiol 1994;4:742-751.
47. Hoshimaru M, Ray J, Sah DW, Gage FH: Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 1996;93:1518-1523.
48. Ryder EF, Snyder EY, Cepko CL: Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J Neurobiol 1990;21:356-375.
49. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-12851.
50. Tang Y, Shah K, Messerli SM, Snyder E, Breakefield XO, Weissleder R: In vivo tracking of neuronal progenitor cell migration to glioblastomas. Hum Gene Ther 2003;14:1247-1254.
51. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY: Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 2002;20:1103-1110.
52. Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, Raghupathi R, Lenzlinger PM, Lifshitz J, Boockvar J, Neugebauer E, Snyder EY, McIntosh TK: Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurg 2002;51:1043-1052.
53. Parent JM, Yu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH: Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 1997;17:3727-3738.
54. Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M, Lindvall O: Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci USA 1997;94:10432-10437.
55. Liu J, Solway K, Messing RO, Sharp FR: Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 1998;18:7768-7778.
56. Arvidsson A, Kokaia Z, Lindvall O: N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci 2001;14:10-18.
57. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, Greenberg DA: Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci USA 2001;98:4710-4715.
58. Gu W, Brannstrom T, Wester P: Cortical neurogenesis in adult rats after reversible photothrombotic stroke. J Cereb Blood Flow Metab 2000;20:1166-1173.
59. Magavi SS, Leavitt BR, Macklis JD: Induction of neurogenesis in the neocortex of adult mice. Nature 2000;405:951-955.
60. Reiss K, Mentlein R, Sievers J, Hartmann D: Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 2002;115:295-305.
61. Fallon J, Reid S, Kinyamu R, Opole I, Opole R, Baratta J, Korc M, Endo TL, Duong A, Nguyen G, Karkehabadhi M, Twardzik D, Patel S, Loughlin S: In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci USA 2000;97:14686-14691.
62. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002;8:963-970.
63. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA: Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001;15:1311-1333.
64. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994;91:7727-7731.
65. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD: Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994;9:2313-2320.
66. Leonard JR, D'Sa C, Klocke BJ, Roth KA: Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure. Oncogene 2001;20:8281-8286.
67. Merlo A: Genes and pathways driving glioblastomas in humans and murine disease models. Neurosurg Rev 2003;26:145-158.
68. Li L, Liu F, Ross AH: PTEN regulation of neural development and CNS stem cells. J Cell Biochem 2003;88:24-28.
69. Callaghan DA, Dong L, Callaghan SM, Hou YX, Dagnino L, Slack RS: Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity. Dev Biol 1999;207:257-270.
70. Oliver TG, Gransfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ: Transcriptional profiling of the Sonic hedgehog response: A critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 2003;100:7331-7336.
71. Recht L, Jang T, Savarese T, Litofsky NS: Neural stem cells and neuro-oncology: Quo vadis? J Cell Biochem 2003;88:11-19.
72. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
73. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
74. Lois C, Alvarez-Buylla A: Long-distance neuronal migration in the adult mammalian brain. Science 1994;264:1145-1148.
75. Lois C, Garcia-Verdugo JM, Alverez-Buylla A: Chain migration of neuronal precursors. Science 1996;271:978-981.
76. Brown AB, Yang W, Schmidt NO, Carroll R, Leishear KK, Rainov NG, Black PM, Breakefield XO, Aboody KS: Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 2003;14:1777-1785.
77. Radner H, el-Shabrawi Y, Eibl RH, Brustle O, Kenner L, Kleihues P, Wiestler OD: Tumor induction by ras and myc oncogenes in fetal and neonatal brain: Modulating effects of developmental stage and retroviral dose. Acta Neuropathol (Berl) 1993;86:456-465.
78. Surawicz TS, Davis F, Freels S, Laws ERJ, Menck HR: Brain tumor survival: Results from the National Cancer Data Base. J Neurooncol 1998;40:151-160.
79. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL: T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 1997;159:4415-4425.
80. Black KL, Chen K, Becker DP, Merrill JE: Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 1992;77:120-126.
81. Visted T, Enger PO, Lund-Johansen M, Bjerkvig R: Mechanisms of tumor cell invasion and angiogenesis in the central nervous system. Front Biosci 2003;8:289-304.
82. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A, Cattaneo E: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2002;6:447-450.
83. Faber C, Terao E, Morga E, Heuschling P: Interleukin-4 enhances the in vitro precursor cell recruitment for tumor-specific T lymphocytes in patients with glioblastoma. J Immunother 2000;23:11-16.
84. Ehtesham M, Kabos P, Gutierrex MA, Chung NH, Griffith TS, Black KL, Yu JS: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002;62:7170-7174.
85. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ: Recombinant IL-12 administration induces tumor regression in association with IFN-production. J Immunol 1994;153:1697-1706.
86. Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villareal LP, Black KL, Yu JS: In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 2002;9:9-15.
87. Jean WC, Spellman SR, Wallenfriedman MA, Hall WA, Low WC: Interleukin-12-based immunotherapy against rat 9L glioma. Neurosurgery 1998;42:850-856.
88. Aghi M, Hochberg F, Breakefield XO: Prodrug-activating enzymes in cancer gene therapy. J Gene Med 2000;2:148-164.
89. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 1991;252:854-856.
90. Kaplitt MG, Tjuvajev JG, Leib DA, Berk J, Pettigrew DK, Posner JB, Pfaff DW, Rabkin SD, Blasberg RG: Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. J Neurooncol 1994;19:137-147.
91. Boviatsis EJ, Scharf JM, Chase M, Harrington K, Kowall NW, Breakefield XO, Chiocca EA: Antitumor activity and reporter gene transfer into rat brain tumors inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Gene Ther 1994;1:323-331.
92. Pyles RB, Thompson RL: Evidence that herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J Virol 1994;68:4963-4972.
93. Kramm CM, Chase M, Herrlinger U, Jacobs A, Pechan P, Rainov NG, Sena-Esteves M, Aghi M, Barnett FH, Chiocca EA, Breakefield XO: Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum Gene Ther 1997;8:2057-2068.
94. Coukos G, Makrigiannakis A, Kang EH, Caparelli D, Benjamin I, Kaiser LR, Rubin SC, Albelda SM, Molnar-Kimber KL: Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancer. Clin Cancer Res 1999;5:1523-1537.
95. Sena-Esteves M, Saeki Y, Camp S, Chiocca EA, Breakefield XO: Single step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein Barr virus hybrid amplicons. J Virol 1999;73:10426-10439.
96. Hampl JA, Camp SM, Mydlarz WK, Hampl M, Ichikawa T, Chiocca EA, Louis DN, Sena-Esteves M, Breakefield XO: Potentiated gene delivery to tumor using herpes simplex virus/Epstein Barr/RV tribrid amplicon vectors. Hum Gene Ther 2003;14:611-626.
97. Mydlarz WK, Camp SM, Sena-Esteves M, Snyder EY, Breakefield XO, Hampl JA: Migratory neuroprogenitor cells target therapeutic retrovirus vectors to intracranial gliomas in mice. Mol Ther 2002;5:A1356.
98. Schneider P, Tschopp J: Apoptosis induced by death receptors. Pharm Acta Helv 2000;74:281-286.
99. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309-1312.
100. Reed JC: Cytochrome c: Can't live with it - Can't live without it. Cell 1997;91:559-562.
101. Thornberry NA, Lazebnik Y: Caspases: Enemies within. Science 1998;281:1312-1316.
102. Walczak H, Krammer PH: The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000;256:58-66.
103. Pitti RM, Marsters SA, Ruppert S, Donajue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996;271:12687-12690.
104. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673-682.
105. Pollack IF, Erff M, Ashkenazi A: Direct stimulation of apoptotic signaling by soluble Apo21/tumor necrosis factor-related apoptosis-induced ligand leads to selective killing of glioma cells. Clin Cancer Res 2001;7:1362-1369.
106. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815-818.
107. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwill RG, Rauch CT: TRAIL-R2: A novel apoptosis-mediated receptor for TRAIL. EMBO J 1997;16:5386-5397.
108. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA: Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 1997;186:1165-1170.
109. Pan G, Ni J, Yu G, Wei YF, Dixit VM: TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 1998;424:41-45.
110. Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA: TRAIL: A mechanism of tumor surveillance in an immune privileged site. J Immunol 2002;169:4739-4744.
111. Dorr J, Bechmann I, Waiczies S, Aktas O, Walczak H, Krammer PH, Nitsch R, Zipp F: Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 2002;22:RC209.
112. Miura Y, Misawa N, Kawano Y, Okada H, Inagaki Y, Yamamoto N, Ito M, Yagita H, Okumura K, Mizusawa H, Koyanagi Y: Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci USA 2003;100:2777-2782.
113. Rubio N, Martin-Clemente B, Lipton HL: High-neurovirulence GDVII virus induces apoptosis in murine astrocytes through tumor necrosis factor (TNF)-receptor and TNF-related apoptosis-inducing ligand. Virology 2003;311:366-375.
114. Matysiak M, Jurewicz A, Askolski D, Selmaj K: TRAIL induces death of human ologodendrocytes isolated from adult brain. Brain 2002;125:2469-2480.
115. Inoue H, Shiraki K, Yamanaka T, Ohmori S, Sakai T, Deguchi M, Okano H, Murata K, Sugimoto K, Nakano T: Functional expression of tumor necrosis factor-related apoptosis-inducing ligand in human colonic adenocarcinoma cells. Lab Invest 2002;82:1111-1119.
116. MacFarlane M: TRAIL-induced signalling and apoptosis. Toxicol Lett 2003;139:89-97.
117. Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM, Phillips PC: Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 2000;19:4604-4610.
118. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N: Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 2000;60:4315-4319.
119. Ivanov VN, Bhoumik A, Ronai Z: Death receptors and melanoma resistance to apoptosis. Oncogene 2003;22:3152-3161.
120. Wang S, El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003;22:8628-8633.
121. Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL: Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 2000;165:2886-2894.
122. Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B: Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61:3330-3338.
123. Seol JY, Park KH, Hwang CI, Park WY, Yoo CG, Kim YW, Han SK, Shim YS, Lee CT: Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Cancer Gene Ther 2003;10:540-548.
124. Shah K, Tang Y, Breakefield X, Weissleder R: Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 2003;22:6865-6872.
125. Lynch DH, Andreason A, Maraskovsky E, Whitmore J, Miller RE, Schuh JC: Flt3 ligand induces tumor regression and anti-tumor immune responses in vivo. Nat Med 1997;3:625-631.
126. Shah K, Jacobs A, Breakefield XO, Weissleder R: Molecular imaging of gene therapy for cancer. Gene Ther 2004;11:1175-1187.